Not exact matches
Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of
pulmonary fibrosis and
pulmonary hypertension, two respiratory diseases that are almost invariably
fatal.
Researchers at UT Southwestern Medical Center have identified mutations in two genes that cause a
fatal lung scarring disease known as familial
pulmonary fibrosis.
A progressive scarring of the lungs with no effective treatment, idiopathic
pulmonary fibrosis (IPF) affects approximately 50,000 Americans annually, and like some cancers often is
fatal within three years.
A team of scientists from the UNC School of Medicine and North Carolina State University (NCSU) has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic
pulmonary fibrosis (IPF), chronic obstructive
pulmonary disease (COPD), and cystic
fibrosis — often -
fatal conditions that affect tens of millions of Americans.